You are here: Industry Insights > Recipharm

News List

Recipharm, Medspray Launch Resyca JV contractpharma
February 02, 2021
Recipharm and Medspray, a manufacturer of high-tech spray nozzles, have established Resyca BV, a joint venture to develop and exploit the softmist spray nozzle technology for pharmaceutical applications.
Recipharm Signs Manufacturing Deal with Enzymatica contractpharma
January 22, 2021
Recipharm, a contract development and manufacturing organization (CDMO), and Enzymatica, a Swedish life science company specializing in products with a protective barrier, have signed a broadened contract for the manufacture of ColdZyme.
Recipharm, Moderna sign deal for manufacturing, fill-finish of COVID-19 vaccines expresspharma
December 31, 2020
They have reached an agreement to support formulation and fill-finish a part of the Moderna COVID-19 vaccine supply outside of the US.
EQT makes $2.8 bn bid for Recipharm expresspharma
December 15, 2020
EQT said it was bidding 220 crowns per Recipharm share, a 22.9 per cent premium to Recipharm’s closing price.
Recipharm Expands API Manufacturing Capabilities contractpharma
December 10, 2020
Global contract development and manufacturing organization (CDMO), Recipharm, has unveiled an investment and capacity expansion at its facility in Israel.
Recipharm Inks Covid-19 Vax Pact with Moderna contractpharma
December 02, 2020
Signs of letter of intent for aseptic fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate (mRNA-1273).
Recipharm, Medspray Establish JV contractpharma
November 18, 2020
Recipharm AB and Medspray BV, a manufacturer of high tech spray nozzles, have established a joint venture known as Resyca BV to develop and exploit the softmist spray nozzle technology for pharmaceutical applications.
Recipharm Invests €2.6M in Kaysersberg Facility contractpharma
October 16, 2020
The Kaysersberg facility specializes in producing sterile liquids for therapeutic areas including eye care and ear drops.
Recipharm, Arcturus Ink LUNAR-COV19 Vax Mfg. Pact contractpharma
October 10, 2020
Recipharm to support the manufacture of ARCT-021, Arcturus’ COVID-19 vaccine candidate that is in an ongoing Phase I/II clinical trial.
Sobrera, Recipharm Collaborate to Advance AUD Treatment contractpharma
October 09, 2020
To provide formulation development and manufacturing of SO-001, a new oral treatment for Alcohol Use Disorder.

Previous page 1 2 3 4 5 Next page